Overview

Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, tolerability and pharmacokinetics of PF-04287881 after a single oral dose in healthy adult volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer